Powder: -20°C for 3 years | In solvent: -80°C for 1 year
Mal-(CH2)5-Val-Cit-PAB-Eribulin is a potent antitumor ADC drug-linker conjugate that utilizes Eribulin, an anti-microtubule agent, connected through the Mal-(CH2)5-Val-Cit-PAB linker.
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
1 mg | Inquiry | $ 314.00 | |
5 mg | Inquiry | $ 813.00 | |
10 mg | Inquiry | Inquiry | |
50 mg | Inquiry | Inquiry |
Description | Mal-(CH2)5-Val-Cit-PAB-Eribulin is a potent antitumor ADC drug-linker conjugate that utilizes Eribulin, an anti-microtubule agent, connected through the Mal-(CH2)5-Val-Cit-PAB linker. |
In vitro | Eribulin (E7389) is a microtubule targeting agent that is used for the research of metastatic breast cancer. Eribulin inhibits the proliferation of cancer cells by binding microtubule proteins and microtubules[2]. |
Synonyms | Mal-(CH2)5-Val-Cit-PAB-Eribulin |
Molecular Weight | 1328.565 |
Formula | C69H97N7O19 |
CAS No. | 2130869-21-3 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
Mal-(CH2)5-Val-Cit-PAB-Eribulin 2130869-21-3 Mal(CH2)5ValCitPABEribulin Mal-(CH-2)5-Val-Cit-PAB-Eribulin Mal (CH2)5 Val Cit PAB Eribulin inhibitor inhibit